Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors

National Medical Journal of India

Volumn 17, Issue 1, 2004, Pages 19-21

  Sharma, R R ^a   Cheema, Ramandeep ^a   Vajpayee, Meenu ^a   Rao, Usha ^a   Kumar, Sudarshan ^a   Marwaha, Neelam ^a   Agnihotri, S K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD EXAMINATION; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GIEMSA STAIN; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MALARIA; PLASMODIUM; SCREENING TEST; SYPHILIS; VENEREAL DISEASE REACTION TEST; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; DISEASE TRANSMISSION, HORIZONTAL; HUMANS; INDIA; MALARIA; PREVALENCE; SAFETY; SEROEPIDEMIOLOGIC STUDIES;

EID: 1842788062     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 2001;44:409-12.
2. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors. Prevalence and trends 1989-1996. Vox Sang 1997;73:70-3.
3. Country scenario update: National AIDS Control Program India, National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India.
4. Choudhury N, Ramesh V, Saraswat S, Naik S. Effectiveness of mandatory transmissible diseases screening in Indian blood donors. Indian J Med Res 1995;101:229-32.
5. Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti HCV) in Madurai, south India. Indian J Med Sci 2000;54:270-3.
6. Srikrishna A, Sitalakshmi S, Damodar P. How safe are our safe donors? Indian J Pathol Microbiol 1999;42:411-16.
7. Tallur SS, Shahapurkar PA, Krishna BVS. Prevalence of HIV infection among blood donors in North Karnataka. Indian J Med Microbiol 1997;15:123-5.
8. Kamat HA, Banker DD, Koppikar GV. Human immunodeficiency viruses types 1 and 2 infection among replacement blood donors in Mumbai (Bombay). Indian J Med Sci 2000;54:43-51.
9. Choudhury N, Ayagiri A, Ray VL. True HIV seroprevalence in Indian blood donors. Transfus Med 2000;10:1-4.
10. Rose D, Sudarsanam A, Padankatti T, Babu PG, John TJ. Increasing prevalence of HIV antibody among blood donors monitored over 9 years in one blood bank. Indian J Med Res 1998;108:42-4.
11. Makroo RN, Salil P, Vashist RP, Shivlal. Trends of HIV infection in the blood donors of Delhi. Indian J Pathol Microbiol 1996;39:139-42.
12. Bhushan N, Pulimood BR, Babu PG, John TJ. Rising trend in the prevalence of HIV infection among blood donors. Indian J Med Res 1994;99:195-7.
13. Infectious disease testing for blood transfusions. NIH consensus statement. Bethesda, Maryland, USA. US PHS, NIH, 1995 Jan 9-11,13 (1):1-27.
14. Busch MP. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing. Vox Sang 1998;74 (Suppl 2):147-54.